pharmaphorum

SEPTEMBER 6, 2021

UK researchers have used artificial intelligence (AI) to develop a way to identify patients with heart failure who would benefit from treatment with beta blockers, by interrogating data from nine landmark clinical trials. The study applied machine learning to trial data involving 15,659 patients who were being treated for heart failure with reduced ejection fraction (HFrEF), a form of heart failure where the left side of the heart isn’t able to pump blood effectively around the body.

145

145

Pharma Times

SEPTEMBER 6, 2021

UK’s chief medical officers will now provide ‘further advice’ on COVID-19 vaccination in this age group

Vaccines 148

Vaccines 148

NY Times

SEPTEMBER 7, 2021

An intubated patient was prescribed the deworming drug by his doctor. Federal health officials have said that it has not been shown to be effective against the coronavirus and that it can be toxic in humans.

Hospitals 98

Hospitals 98

Pharma Mirror

SEPTEMBER 7, 2021

The Hague, Pharmacists must be allowed to do more to manage respiratory conditions in communities if the urgent need to address the harmful effects of air pollution on health is to be met, the International Pharmaceutical Federation (FIP) said today. The expansion of pharmacists’ roles in mitigating the health threats of air pollution is among several actions described in a call to action issued by FIP, marking the United Nations International Day of Clean Air for Blue Skies.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

SEPTEMBER 8, 2021

An artificial intelligence algorithm was able to detect signs of lung cancer on CT scans a year earlier than with traditional methods, according to a new study. CT (computed tomography) scans are already used to spot signs of lung tumours, followed by a biopsy or surgery to confirm whether the tumour is malignant, according to Benoît Audelan, a researcher at France’s National Institute for Research in Digital Science and Technology.

Hospitals 107

Hospitals 107

Pharma Times

SEPTEMBER 9, 2021

The trial will aim to enrol 640 healthy adults, aged 50- to 70-years-old

Vaccines 143

Vaccines 143

Pharma Mirror

SEPTEMBER 7, 2021

Increasing burden of chronic diseases and rising awareness about necessity of early warning signs are fuelling the demand of remote patient monitors With the COVID-19 pandemic, health systems or hospitals rapidly adopted remote patient monitoring technology to maintain social distancing and thereby control viral spread. Patients suffering from COVID – 19 need to monitor blood oxygen level and heart rate regularly.

Hospitals 96

Hospitals 96

pharmaphorum

SEPTEMBER 8, 2021

A 20% to 25% reduction in staffing at the UK Medicines and Healthcare products Regulatory Agency (MHRA) risks undermining the ability of the authority to fulfil its role, according to trade unions. In an open letter to Health Secretary Sajid Javid, Prospect, Unite and three other unions say the decision to slash the MHRA’s current 1,200 workforce by up to 300 workers means that “regulatory decisions may suffer.” Fewer staff will therefore be asked to cover more ground with fewe

98

98

Drug Patent Watch

SEPTEMBER 8, 2021

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are fifteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

96

96

NY Times

SEPTEMBER 4, 2021

The drug has spared hundreds of millions of Africans from serious parasites, but clinical trials have repeatedly failed to show that it is effective against Covid. Still, U.S. demand is high.

95

95

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

SEPTEMBER 9, 2021

The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimerâs.

Mayo Clinic 98

Mayo Clinic 98

pharmaphorum

SEPTEMBER 10, 2021

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. The Singapore startup, which is partnering with the Mayo Clinic on the clinics, said the cash injection will also go towards the development of its pipeline of digital therapeutics (DTx) for Alzheimer’s disease and other neurodegenerative conditions.

Mayo Clinic 97

Mayo Clinic Pharmaceutical Companies Pharmaceutical Companies 97

Drug Channels

SEPTEMBER 9, 2021

Cardinal Health recently released the annual report for its 2021 fiscal year, which ended on June 30. See the links below. Today, I delve into the financials behind Cardinal’s relationship with its largest customer, CVS Health. In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago.

84

84

Pharma Times

SEPTEMBER 7, 2021

New analysis from the Health Foundation's REAL Centre warns extra support and investment needed

109

109

Outsourcing Pharma

SEPTEMBER 10, 2021

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

Vaccines 105

Vaccines Drug Development 105

pharmaphorum

SEPTEMBER 6, 2021

Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered drugmaker filed for bankruptcy last year, after proposing a $1.6 billion payout to settle lawsuits claiming that its marketing of opioid painkillers helped to fuel an epidemic in addiction that has claimed hundreds of thousands of lives in the US alone.

Documentation 96

Documentation Immunity Immunization 96

Drug Channels

SEPTEMBER 8, 2021

Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Friday, September 24, 2021, from 12:00 p.m. to 1:30 p.m. ET This page describes the event and explains how to purchase a registration. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series.

Drug Pricing 72

Drug Pricing Biosimilars Hospitals 72

Pharma Times

SEPTEMBER 8, 2021

The independent data monitoring committee (DMC) has recommended continuation of the Phase III trial

101

101

Outsourcing Pharma

SEPTEMBER 8, 2021

A leader from Illingworth Research Group outlines exactly what makes a good mobile research nurse and what their duties in decentralized trials are.

105

105

pharmaphorum

SEPTEMBER 6, 2021

Amgen and partner AstraZeneca have said their recently filed severe asthma drug tezepelumab has shown impressive results in patients who also have nasal polyps, a common complication of the respiratory disease. Tezepelumab reduced the annualised asthma exacerbation rate (AAER) by 86% in a subgroup of people with severe, uncontrolled asthma and polyps in the NAVIGATOR study, topping the 41% reduction achieved with the first-in-class TSLP inhibitor in the overall study population.

Hospitals 96

Hospitals 96

Drug Patent Watch

SEPTEMBER 10, 2021

Annual Drug Patent Expirations for TRIGLIDE Triglide is a drug marketed by Skyepharma Ag and is included in one NDA. There is one patent protecting this drug. This drug has…. The post New patent expiration for Skyepharma Ag drug TRIGLIDE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 10, 2021

Treatment approved for adults and adolescents with moderate to severe atopic dermatitis

104

104

Outsourcing Pharma

SEPTEMBER 9, 2021

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

98

98

pharmaphorum

SEPTEMBER 9, 2021

Increasing public spending on healthcare in Central and Eastern Europe (CEE) could not only result in healthier populations, it could also improve the region’s economic prosperity. That’s according to a new report commissioned by the European Federation of Pharmaceutical Industry and Associations (EFPIA), which explores the health investment and outcomes.

Biosimilars 93

Biosimilars Hospitals 93

Drug Patent Watch

SEPTEMBER 9, 2021

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…. The post New patent for Boehringer Ingelheim drug JARDIANCE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 6, 2021

Expert Medicals – one of the largest PCR travel test providers in the UK this summer – has received a ‘high number of complaints’

75

75

Outsourcing Pharma

SEPTEMBER 8, 2021

According to an Oracle Health Sciences leader, companies looking to take on decentralized trials should keep a few things in mind before taking the plunge.

96

96

pharmaphorum

SEPTEMBER 8, 2021

NICE has reversed its position on Johnson & Johnson’s oral prostate cancer therapy Erleada in patients with hormone-relapsed or hormone sensitive tumours, backing NHS use of the drug. The change of heart comes after J&J’s Janssen pharma unit offered an improved discount on Erleada (apalutamide), according to the cost-effectiveness watchdog in its final appraisal determination, which makes the drug an option for around 8,000 patients in England and Wales.

Chemotherapy 89

Chemotherapy 89

Drug Patent Watch

SEPTEMBER 9, 2021

Annual Drug Patent Expirations for COTELLIC Cotellic is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent for Genentech Inc drug COTELLIC appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 10, 2021

Xeljanz is the second drug to be recommended as part of NICE’s new approach to the cost comparison fast track appraisal process

81

81

Outsourcing Pharma

SEPTEMBER 7, 2021

A leader from the home trial services provder says patientsâ increasing awareness of clinical research has how trial teams should consider their approach.

85

85

pharmaphorum

SEPTEMBER 7, 2021

Servier and Neurochlore have been forced to admit defeat in their bid to bring the first drug to market for people with autism spectrum disorder (ASD), after a comprehensive fail for their bumetanide candidate in two phase 3 trials. The French partners said today that there was “no sign of effectiveness” for bumetanide compared to placebo in 422 children and adolescents with ASD enrolled in the two studies, which have now been halted.

83

83

Pharma Mirror

SEPTEMBER 9, 2021

Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment at its site in Dudley, UK to create the company’s centre of excellence for research into commercial applications of continuous flow chemistry. Announcement of the investment follows the appointment of Professor Ian R.

Research Laboratories 52

Research Laboratories 52

Pharma Times

SEPTEMBER 6, 2021

New government body will be co-led by deputy chief medical officer Jeanelle de Gruchy

101

101

Outsourcing Pharma

SEPTEMBER 8, 2021

A representative from Cmed explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

91

91